Level 42 AI

Level 42 AI, Inc., a Silicon Valley startup, is a team of 16 employees dedicated to developing innovative healthcare solutions. Level 42 AI specializes in software-defined hardware that captures and synchronizes various physiological data streams. Their technology analyzes these data snippets, similar in principle to the music identification app Shazam, to predict and quantify health states. Their primary focus is on developing a rapid, non-invasive, and affordable mass screening test for COVID-19, which could be used in a variety of settings, including workplaces, schools, and public transportation. The company is conducting clinical studies in collaboration with Johns Hopkins School of Medicine and University of California-San Francisco to validate COVID-19 biosignatures. Level 42 AI's proprietary algorithm utilizes advanced machine learning techniques to identify early cellular and tissue changes and the body's immune response to SARS-CoV-2 infection. Their goal is to unveil robust biosignatures for various conditions, including COVID-19, MIS-C, asthma, COPD, cystic fibrosis, tuberculosis, pulmonary arterial hypertension, acute respiratory distress syndrome, carotid artery disease, coronary artery disease, congestive heart failure, pain, and depression. For more information about Level 42 AI's innovative solutions, visit their website at level42.ai.